(F1-say (R-ARG0 (F3-Writing (V writing ) (ARGM-LOC in plos one ) ) (ARG0 they ) ) (V say ) (ARG1 (F2-encourage (ARG0 the gene fault ) (ARGM-MOD may ) (V encourage ) (ARG1 the formation of blood clots - the ultimate cause of most heart attacks and strokes ) ) ) )	(F1-hope (ARG0 scientists ) (V hope ) (ARG1 (F2-help (ARG0 gene tests ) (ARGM-MOD may ) (V help ) (ARG2 doctors ) (ARGM-TMP one day ) (ARG1 to (F3-pinpoint (ARG0 *trace-F2-ARG2* ) (V pinpoint ) (ARG1 (F4-suffer (ARG0 individuals ) more likely to (V suffer ) (ARG1 these conditions ) ) ) ) ) ) ) )	(F1-say (ARGM-DIS but ) (ARG0 experts ) (V say ) (ARG1 (F2-have (ARG0 lifestyle factors such as smoking and exercise ) (V have ) (ARG1 the greatest influence on risk ) ) ) )	(F1-carries (ARG0 around one in 10 people in the caucasian population ) (V carries ) (ARG1 (F2-named (ARG1 this variation of the gene ) , (V named ) (ARG2 pia2 ) ) ) )	(F1-reviewed (ARGM-DIS and ) (ARG0 researchers from king 's college london ) (V reviewed ) (ARG1 (F2-involving (ARG2 more than 80 studies ) (V involving ) (ARG1 about 50,000 people - the largest analysis of this genetic fault to date ) ) ) )	(F1-found (ARG0 they ) (V found ) (ARG1 (F2-were (ARG1 individuals with pia2 ) (V were ) (ARG2 more likely to (F4-have (ARG0 *trace-F2-ARG1* ) (V have ) (F3-caused (ARG1 a stroke ) ) - (V caused ) (ARG0 by (F5-blocking (ARG0 a blood clot ) (V blocking ) (ARG1 blood supply to the brain ) ) ) ) - than those without the gene ) ) ) )	(F1-calculate (ARG0 scientists ) (V calculate ) (ARG1 (F2-increases (ARG0 the gene ) (V increases ) (ARG1 a person 's risk of (F3-having (V having ) (ARG1 a stroke ) ) ) (ARG2 by 10 - 15 % ) ) ) )	(F0 but (F1-depends (ARG0 (F3-is (ARG2 how significant ) (ARG1 this increase ) (V is ) ) ) (V depends ) (ARG1 on (F2-influenced (ARG1 an individual 's baseline risk ) - (V influenced ) (ARG0 by factors such as smoking , diet , weight and exercise ) ) ) ) , (F4-say (ARG0 the scientists ) (V say ) ) )	(F1-rises (ARGM-DIS and ) (ARGM-ADV for people with two copies of the gene ) (ARG1 the risk ) (V rises ) (ARG2 by up to 70 % ) (ARG3 from this baseline ) )	(F1-show (ARGM-LOC in (F3-published (ARG1 a second study ) (V published ) (ARGM-LOC in the same journal ) ) ) , (ARG0 the scientists ) (V show ) (ARG1 (F2-linked (ARG1 pia2 ) is (ARGM-DIS also ) (V linked ) (ARG2 to an (F4-increased (V increased ) (ARG1 risk of heart attacks ) ) in people under 45 ) ) ) )	(F1-say (ARG1 (F2-needed (ARG1 more research ) is (V needed ) (ARGM-PRP to (F3-see (V see ) (ARG1 whether this (F4-holds (V holds ) (ARG1 true ) (ARGM-GOL for the whole population ) ) ) ) ) ) ) , (ARG0 they ) (V say ) )	(F1-have (ARG0 about 150,000 people ) (V have ) (ARG1 a stroke in the uk ) (ARGM-TMP each year ) ) and (F2-recorded (ARG1 more than 100,000 heart attacks ) are (V recorded ) (ARGM-TMP annually ) )	(F1-caused (ARG1 both thrombotic strokes @@ the most common kind @@ and heart attacks ) are (V caused ) (ARG0 by blockage of blood vessels in the heart and brain - ultimately through the formation of clots ) )	(F1-appears (ARG1 the faulty gene ) (V appears ) (C-ARG1 to (F2-affect (ARG0 *trace-F1-ARG1* ) (V affect ) (ARG1 (F3-called (ARG1 a protein ) (V called ) (ARG2 glycoprotein iiia ) ) - present on platelets , natural clotting cells in the blood ) ) ) )	(F1-help (ARG0 platelets ) (V help ) (ARG1 (F2-trigger (ARG0 *trace-F1-ARG0* ) (V trigger ) (ARG1 the formation of clots to (F5-stop (V stop ) (ARG1 bleeding ) (ARGM-TMP after injury ) ) ) ) ) ) . but (F3-say (ARG0 scientists ) (V say ) (ARG1 (F4-render (ARG0 (F6-carrying (V carrying ) (ARG1 the gene ) ) ) (ARGM-MOD may ) (V render ) (ARG1 them overactive ) ) ) )	(F1-caution (ARG0 they ) (V caution ) (ARG1 that (F2-play (ARGM-ADV overall ) (ARG0 the genes ) (V play ) (ARG1 a smaller role in risk than (F3-established (ARGM-ADV more ) (V established ) (ARG1 factors ) ) , such as high blood pressure and obesity ) ) ) )	(F1-help (ARGM-DIS but ) (ARG0 (F5-developing (V developing ) (ARG1 a genetic test ) ) ) (ARGM-MOD could ) (V help ) (ARG1 (F2-predict (ARG0 *trace-F1-ARG0* ) (V predict ) (ARG1 people at highest risk ) ) ) , (ARGM-ADV (F3-allowing (V allowing ) (ARG1 (F4-suggest (ARG0 doctors ) to (V suggest ) (ARG1 more potent medication or lifestyle changes ) ) ) ) ) ) , (F6-say (ARG0 they ) (V say ) )	(F1-told (ARG0 (F3-led (ARG0 prof albert ferro ) , of king 's college london , (R-ARG0 who ) (V led ) (ARG1 the research ) ) , ) (V told ) (ARG2 the bbc ) : " (ARG1 (F2-need (ARG0 we ) (ARGM-MOD would ) (ARGM-TMP now ) (V need ) (ARG1 to (F5-validate (ARG0 *trace-F2-ARG0* ) (V validate ) (ARG1 this test ) ) and (F4-see (ARG0 *trace-F2-ARG0* ) (V see ) (ARG1 (F6-is (ARG2 how useful ) (ARG1 it ) (V is ) (ARGM-LOC in the clinical world ) ) ) ) ) ) ) )	(F1-said (ARG0 dr shamim quadir , of the stroke association , ) (V said ) : " (ARG1 (F2-are (ARG1 these latest results ) (V are ) (ARG2 an important step forward in stroke research ) ) ) )	(F1-hope (ARG0 we ) (V hope ) (ARG1 (F2-lead (ARG0 the findings from this study ) (ARGM-MOD could ) (V lead ) (ARG2 to (F3-are (ARG1 many more people ) (R-ARG1 who ) (V are ) (ARG2 most at risk of (F4-identified (ARG1 this devastating condition ) ) ) being (V identified ) ) ) ) ) )	(F1-be (ARGM-DIS however ) , (ARGM-ADV if (F3-have (ARG0 you ) (F5-have (ARG0 *trace-F3-ARG0* ) (V have ) (ARG1 a family history of stroke ) ) or (V have ) (ARG1 any other risk factors ) ) ) , (F2-mean (ARGM-DIS *trace-F1-ARGM-DIS* ) (ARGM-ADV *trace-F1-ARGM-ADV* ) (ARG0 this ) does (ARGM-NEG not ) (V mean ) (ARG1 (F6-is (ARG1 the condition ) (V is ) (ARG2 inevitable ) ) ) ) . regular exercise , (ARG1 (F7-eating (V eating ) (ARG1 a balanced diet ) ) and (F8-stopping (V stopping ) (ARG1 smoking ) ) ) (ARGM-MOD can ) (V be ) (ARG2 (F4-reduce (ARG0 important ) steps to (ARGM-ADV significantly ) (V reduce ) (ARG1 your stroke risk ) ) ) )	(F1-said (ARG0 prof jeremy pearson , of the british heart foundation , ) (V said ) : (ARG1 " it (F2-is (V is ) (ARG2 as yet uncertain ) (ARG1 whether (F3-be (ARG1 (F4-detect (ARG0 a genetic test ) to (V detect ) (ARG1 a variation in this protein ) ) ) (ARGM-MOD would ) (V be ) (ARG2 beneficial for patients in everyday practice ) ) ) ) ) )	(F1-monitored (ARG1 (F4-are (ARG1 all patients ) (R-ARG1 who ) (V are ) (ARG2 at risk ) ) ) (ARGM-MOD should ) be (V monitored ) (ARGM-PRP to (F2-see (V see ) (ARG1 whether or not (F3-have (ARG0 lifestyle changes or medication ) (V have ) (ARG1 a positive impact on the more standard major risk factors such as high blood pressure and high cholesterol ) ) ) ) ) )
